Atyr Pharma Inc (ATYR) Stock Price, Quote & News

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitiv...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 731 8389

Fax: 858 731 8394

Website: atyrpharma.com

Address:

10240 Sorrento Valley Road, Suite 300, San Diego, United States

OnlyBuyMoreShareSqueezes Feb. 23 at 9:26 PM

$ATYR third trading day it has closed above 1 , we need to buy as much as we can this week and we keep it all week 1+ , let’s aim for 1.60+ . We got this 💪.

0 · Reply

RocketLabs Feb. 23 at 8:14 PM

$ATYR block print? 👍🏻

1 · Reply

GpsForTheWin009 Feb. 23 at 3:47 PM

$SLS get out now before 80 percent plunge on readout like $ATYR Anson Warrants They sold all shares GET OUT NOW

4 · Reply

RocketLabs Feb. 23 at 1:49 PM

$ATYR new analyst rating outperform! Can't find more details anywhere... Anyone?

1 · Reply

OnlyBuyMoreShareSqueezes Feb. 23 at 1:37 PM

$ATYR buy the ask price 📈📈📈 and hold . Raise those bids 💰🐋📈

0 · Reply

EmproX Feb. 23 at 1:35 PM

$TTMI $ITRG $ATYR $ILAG |\|\|

0 · Reply

Old_Bag Feb. 22 at 6:55 PM

$SLS If this is such a slam dunk of a stock, why isn't this already trading multiples higher? Anything can happen in pharma. Hope you guys remember $ATYR

3 · Reply

UgoGreg Feb. 21 at 5:19 PM

$ATYR https://youtu.be/ygBN8MilTyc

0 · Reply

trader2sde Feb. 21 at 5:13 AM

$ATYR https://www.zerohedge.com/medical/fda-dropping-requirement-2-studies-new-drug-approvals

0 · Reply

ClearCities Feb. 20 at 10:39 PM

$ATYR I think this can get to 3 dollars in a few months

0 · Reply

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2026, 8:00 AM EST - 5 days ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 5, 2026, 4:05 PM EST - 18 days ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

Feb 3, 2026, 2:46 PM EST - 20 days ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

Feb 3, 2026, 8:00 AM EST - 20 days ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Jan 30, 2026, 10:25 PM EST - 23 days ago

U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January

AGMB BOBS EIKN FPS LFTO OFRM OPTN

Jan 30, 2026, 12:21 AM EST - 24 days ago

Ethos Technologies: A Surprisingly Soft Debut

Jan 29, 2026, 12:30 PM EST - 25 days ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 28, 2026, 10:38 PM EST - 25 days ago

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 9:05 PM EST - 25 days ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 23, 2026, 10:45 PM EST - 4 weeks ago

U.S. IPO Weekly Recap: Equipment Rental Rises While Crypto Company Crashes In 2-IPO Week

BTGO EQPT PICS PPHC YSS CLRS

Jan 7, 2026, 8:01 AM EST - 6 weeks ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Jan 2, 2026, 10:35 PM EST - 7 weeks ago

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

OXY BTGO EQPT GRAY IBL KLK MMED

Dec 18, 2025, 8:01 AM EST - 2 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 15, 2025, 2:45 PM EST - 2 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 8, 2025, 3:25 AM EST - 2 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 7, 2025, 9:02 AM EST - 2 months ago

ATYR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 6, 2025, 12:58 PM EST - 2 months ago

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

Dec 4, 2025, 10:56 AM EST - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 3, 2025, 4:21 PM EST - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit – ATYR

Dec 3, 2025, 9:22 AM EST - 2 months ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Dec 1, 2025, 6:32 PM EST - 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Nov 26, 2025, 11:34 AM EST - 3 months ago

The Short List — Top 10 Most Shorted Stocks Right Now

CMBM HIMS HTZ LCID NTLA REPL SOC

Nov 25, 2025, 4:08 PM EST - 3 months ago

aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman

Nov 20, 2025, 8:45 AM EST - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR

Nov 18, 2025, 2:03 PM EST - 3 months ago

ATYR INVESTOR NOTICE: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman

Nov 11, 2025, 9:23 AM EST - 3 months ago

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

Nov 10, 2025, 8:00 AM EST - 3 months ago

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 6, 2025, 4:01 PM EST - 3 months ago

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

Nov 4, 2025, 11:49 AM EST - 3 months ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma

Oct 30, 2025, 11:33 AM EDT - 4 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 30, 2025, 8:45 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR

Oct 28, 2025, 9:34 AM EDT - 4 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

OnlyBuyMoreShareSqueezes Feb. 23 at 9:26 PM

$ATYR third trading day it has closed above 1 , we need to buy as much as we can this week and we keep it all week 1+ , let’s aim for 1.60+ . We got this 💪.

0 · Reply

RocketLabs Feb. 23 at 8:14 PM

$ATYR block print? 👍🏻

1 · Reply

GpsForTheWin009 Feb. 23 at 3:47 PM

$SLS get out now before 80 percent plunge on readout like $ATYR Anson Warrants They sold all shares GET OUT NOW

4 · Reply

RocketLabs Feb. 23 at 1:49 PM

$ATYR new analyst rating outperform! Can't find more details anywhere... Anyone?

1 · Reply

OnlyBuyMoreShareSqueezes Feb. 23 at 1:37 PM

$ATYR buy the ask price 📈📈📈 and hold . Raise those bids 💰🐋📈

0 · Reply

EmproX Feb. 23 at 1:35 PM

$TTMI $ITRG $ATYR $ILAG |\|\|

0 · Reply

Old_Bag Feb. 22 at 6:55 PM

$SLS If this is such a slam dunk of a stock, why isn't this already trading multiples higher? Anything can happen in pharma. Hope you guys remember $ATYR

3 · Reply

UgoGreg Feb. 21 at 5:19 PM

$ATYR https://youtu.be/ygBN8MilTyc

0 · Reply

trader2sde Feb. 21 at 5:13 AM

$ATYR https://www.zerohedge.com/medical/fda-dropping-requirement-2-studies-new-drug-approvals

0 · Reply

ClearCities Feb. 20 at 10:39 PM

$ATYR I think this can get to 3 dollars in a few months

0 · Reply

RocketLabs Feb. 20 at 8:56 PM

$ATYR very stable day! Delisting notice on countdown! 👍🏻👍🏻